Lamzede

velmanase alfa · Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Lamzede, covering 2023-02-16 to 2026-03-02. Get the full timeline:

Most recent: EMA Authorised: Lamzede (velmanase alfa) — Chiesi Farmaceutici S.p.A.